Stockreport

Quince Therapeutics Settles Approximately $16.4 Million of Debt

Quince Therapeutics, Inc.  (QNCX) 
PDF SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Quince Therapeutics, Inc. (Nasdaq: QNCX) today announced the successful settlement of the company’s outstanding obligat [Read more]